- Abbvie Inc To Acquire Cerevel Therapeutics TranscriptDec 07, 2023
- Q3 2023 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptNov 01, 2023€22.2 (+3.74%)Earnings
- Cerevel Therapeutics Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptAug 02, 2023€27.4 (-0.72%)Earnings
- Cerevel Therapeutics Holdings Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptMay 03, 2023€26.6 (-4.32%)Earnings
- Cerevel Therapeutics Holdings Inc at Stifel CNS Days (Virtual) TranscriptMar 29, 2023
- Cerevel Therapeutics Holdings Inc at Cowen Health Care Conference TranscriptMar 06, 2023
- Q4 2022 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptFeb 22, 2023€28.8 (-7.10%)Earnings
- Cerevel Therapeutics Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptNov 08, 2022Earnings
- Cerevel Therapeutics Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptAug 01, 2022Earnings
- Q1 2022 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptMay 10, 2022Earnings
- Cerevel Therapeutics Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Cerevel Therapeutics Holdings Inc at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
- Cerevel Therapeutics Holdings Inc R&D Event TranscriptJan 28, 2021
Abbvie Inc To Acquire Cerevel Therapeutics Transcript
Good day, and thank you for standing by. Welcome to the AbbVie Investor and Analyst Conference Call. (Operator Instructions) Today's call is also being recorded. (Operator Instructions) I would now like to introduce Ms. Liz Shea, Senior Vice President of Investor Relations. Thank you. You may begin.
Good morning, and thank you for joining us for this special conference call to discuss AbbVie's acquisition of Cerevel, which we announced yesterday.
Joining me on the call today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Rob Michael, President and Chief Operating Officer; Jeff Stewart, Executive Vice President and Chief Commercial Officer; Scott Reents, Executive Vice President and Chief Financial Officer; and Roopal Thakkar, Senior Vice President, Development and Regulatory Affairs and Chief Medical Officer; Nicholas Donoghoe, Executive Vice President, Chief Business and Strategy Officer; will also be joining us for the Q&A portion of our call.
Today's events will feature
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)